Dergiler / Turkish Journal of Veterinary and Animal Sciences / 2017 / Cilt: 41 - Sayı: 3

Thromboelastographic evaluation of hemostatic functionin dogs with dilated cardiomyopathy

Sayfa
372–379
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This study showed that alterations of the coagulation status in dogs with DCM could develop independently of serum cTnI elevations.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study aimed to evaluate the hemostatic function by thromboelastography (TEG) and determine if there was an association between the changes in hemostatic parameters and serum cardiac troponin I (cTnI) in dogs with dilated cardiomyopathy (DCM).
📊
Temel Bulgular & Veri:DCM was diagnosed by echocardiography in 19 dogs.
💡
Sonuç & Katkı:This study showed that alterations of the coagulation status in dogs with DCM could develop independently of serum cTnI elevations.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

This study aimed to evaluate the hemostatic function by thromboelastography (TEG) and determine if there was an association between the changes in hemostatic parameters and serum cardiac troponin I (cTnI) in dogs with dilated cardiomyopathy (DCM). DCM was diagnosed by echocardiography in 19 dogs. Ten healthy dogs were selected as controls. Myocardial injury was confirmed by increased serum cTnI levels. Coagulation was assessed by TEG evaluating clot kinetics (reaction time [R] and kinetic time [K]), clot strengthening (alpha [α] angle and G value), platelet function (maximum amplitude [MA] and coagulation-index [CI]), clot stability (LY30, the percentage of lysis 30 min after MA), and global clotting times (activated partial thromboplastin time [aPTT] and prothrombin time [PT]). Dogs with DCM had higher R and K times but lower MA, α-angle, G, and CI compared to controls (P < 0.05). LY30 and PT did not statistically differ between groups, but the aPTT in dogs with DCM was higher than that of the controls. Serum cTnI (median [range], ng/mL) was higher in dogs with DCM (0.25 [0.13 3.1]) than in healthy dogs (0.03 [0.01 0.06]). There was no statistical relation between cTnI and coagulation parameters. This study showed that alterations of the coagulation status in dogs with DCM could develop independently of serum cTnI elevations.

🔖

Bu Makaleye Atıf Yap

KOCATÜRK, M., İNAN, O. E., YILMAZ, Z., LEVENT, P. (2022). Thromboelastographic evaluation of hemostatic functionin dogs with dilated cardiomyopathy. Turkish Journal of Veterinary and Animal Sciences, Cilt: 41 - Sayı: 3, 372–379. https://ajindex.com/articles/615010

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Wendy WA. Cardiovascular Disease in Small Animal Medicine. 3rd ed. London, UK: Manson Publishing; 2011
  2. Martin MW, Stafford Johnson MJ, Strehlau G, King JN. Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases. J Small Anim Pract 2010; 8: 428-436
  3. Oyama MA. Canine cardiomyopathy. In: Smith F, Tilley L, Oyama M, Sleeper M, editors. Manual of Canine and Feline Cardiology. 5th ed. St. Louis, MO, USA: Elsevier; 2016. pp. 141-152
  4. Dukes-McEwan J, Borgarelli M, Tidholm A, Vollmar AC, Häggström J. Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. Journal of Veterinary Cardiology 2003; 5: 7-19
  5. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies. Circulation 2006; 11; 113: 1807-1816
  6. Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley CM, Cleland JG. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J 1994; 127: 607-612
  7. De Lorenzo F, Saba N, Kakkar VV. Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention. Drugs 2003; 63: 565-576
  8. Tarnow I, Falk T, Tidholm A, Martinussen T, Jensen AL, Olsen LH, Pedersen HD, Kristensen AT. Hemostatic biomarkers in dogs with chronic congestive heart failure. J Vet Intern Med 2007; 21: 451-457
  9. Lubas G, Caldin M, Wiinber B, Kristensen AT. Laboratory Testing of Coagulation Disorders. In: Weiss DJ, Wardrop KJ, editors. Schalm’s Veterinary Hematology. 6th ed. Ames, IA, USA: Wiley-Blackwell; 2010. pp. 1082-1100
  10. Bauer N, Eralp O, Moritz A. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use. J Vet Diagn Invest 2009; 21: 641-648
  11. Eralp O, Yilmaz Z, Failing K, Moritz A, Bauer N. Effect of experimental endotoxemia on thrombelastography parameters, secondary and tertiary hemostasis in dogs. J Vet Int Med 2011; 25: 524-531
  12. Kocatürk M, Eralp İnan O, Levent P, Yılmaz Z. Protective effects of S- adenosylmethionine (SAMe) and silybin on hepatorenal and hemostatic functions in dogs with endotoxemia. Turk J Vet Anim Sci 2016; 40: 788-796
  13. Eralp İnan O, Kocatürk M, Mecitoğlu Z, Yılmaz Z. Thromboelastographic evaluation of coagulation in a dog with anticoagulant rodenticide int